title: Kidney cancer in 2016: The evolution of anti-angiogenic therapy for kidney cancer.
authors.affiliation: Memorial Sloan-Kettering Cancer, Center Solid Tumor Oncology Division, 1275 York Avenue, New York 10021, USA.
authors.forename: Chung-Han
authors.initials: CH
authors.lastname: Lee
authors.affiliation: Memorial Sloan-Kettering Cancer, Center Solid Tumor Oncology Division, 1275 York Avenue, New York 10021, USA.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Motzer
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors